Gao Xinyan, Kong Yan, Ning Ying, Tian Tian, Gai Xiaojing, Lei Ke, Cui Zhumei
School of Clinical Medicine, Qingdao University, Qingdao, China.
Department of Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Int J Surg. 2025 Jan 1;111(1):1619-1623. doi: 10.1097/JS9.0000000000002098.
The aim of this study was to investigate the impact of surgical treatment on the survival prognosis of patients with locally advanced cervical cancer (LACC) and to identify factors that may influence the efficacy of surgery. Data from the SEER database (2000-2020) and a hospital (2013-2023) were collected for this investigation. Utilizing multivariable Cox regression analysis, Kaplan-Meier survival analysis, and log-rank tests, we assessed the effects of surgical intervention on overall survival (OS) and disease-specific survival (DSS) in LACC patients. Our results revealed that in the SEER database, the surgical group exhibited significantly better OS and DSS compared to the non-surgical group. Particularly noteworthy was the significantly higher survival rate in the surgical group for patients with tumor diameters less than 6 cm. Furthermore, both OS and DSS were improved in the surgical group regardless of whether the cancer was squamous cell carcinoma or adenocarcinoma. Additionally, patients who underwent surgery combined with radiotherapy had notably better OS and DSS compared to those who received chemoradiotherapy alone. Similarly, our hospital data showed that the surgical group demonstrated significantly better OS than the non-surgical group, especially for patients with tumors smaller than 6 cm in diameter. These findings suggest that surgery combined with radiotherapy may offer more favorable outcomes than chemoradiotherapy alone, particularly for LACC patients with smaller tumors.
本研究的目的是探讨手术治疗对局部晚期宫颈癌(LACC)患者生存预后的影响,并确定可能影响手术疗效的因素。为此研究收集了SEER数据库(2000 - 2020年)和一家医院(2013 - 2023年)的数据。利用多变量Cox回归分析、Kaplan-Meier生存分析和对数秩检验,我们评估了手术干预对LACC患者总生存期(OS)和疾病特异性生存期(DSS)的影响。我们的结果显示,在SEER数据库中,手术组的OS和DSS显著优于非手术组。特别值得注意的是,肿瘤直径小于6 cm的患者手术组的生存率显著更高。此外,无论癌症是鳞状细胞癌还是腺癌,手术组的OS和DSS均有所改善。此外,与单纯接受放化疗的患者相比,接受手术联合放疗的患者的OS和DSS明显更好。同样,我们医院的数据显示,手术组的OS明显优于非手术组,尤其是对于直径小于6 cm的肿瘤患者。这些发现表明,手术联合放疗可能比单纯放化疗提供更有利的结果,特别是对于肿瘤较小的LACC患者。